nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitazoxanide—Acetylsalicylic acid—HSPA5—esophageal cancer	0.111	0.42	CrCbGaD
Nitazoxanide—Urine color abnormal—Capecitabine—esophageal cancer	0.0591	0.0803	CcSEcCtD
Nitazoxanide—Acetylsalicylic acid—TP53—esophageal cancer	0.0456	0.173	CrCbGaD
Nitazoxanide—Chromaturia—Capecitabine—esophageal cancer	0.039	0.053	CcSEcCtD
Nitazoxanide—Meloxicam—PTGS1—esophageal cancer	0.0272	0.103	CrCbGaD
Nitazoxanide—Infection—Carboplatin—esophageal cancer	0.0228	0.031	CcSEcCtD
Nitazoxanide—Salsalate—PTGS1—esophageal cancer	0.0209	0.0791	CrCbGaD
Nitazoxanide—Pain—Carboplatin—esophageal cancer	0.0197	0.0267	CcSEcCtD
Nitazoxanide—Metrorrhagia—Capecitabine—esophageal cancer	0.0195	0.0265	CcSEcCtD
Nitazoxanide—Body temperature increased—Carboplatin—esophageal cancer	0.0182	0.0247	CcSEcCtD
Nitazoxanide—Acetylsalicylic acid—PTGS1—esophageal cancer	0.0156	0.0591	CrCbGaD
Nitazoxanide—Meloxicam—PTGS2—esophageal cancer	0.0155	0.0588	CrCbGaD
Nitazoxanide—Lung disorder—Methotrexate—esophageal cancer	0.0146	0.0199	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Cisplatin—esophageal cancer	0.0128	0.0175	CcSEcCtD
Nitazoxanide—Salsalate—PTGS2—esophageal cancer	0.0119	0.0452	CrCbGaD
Nitazoxanide—Ear pain—Capecitabine—esophageal cancer	0.0118	0.0161	CcSEcCtD
Nitazoxanide—Increased appetite—Capecitabine—esophageal cancer	0.0108	0.0146	CcSEcCtD
Nitazoxanide—Thirst—Capecitabine—esophageal cancer	0.0106	0.0144	CcSEcCtD
Nitazoxanide—Blood creatinine increased—Capecitabine—esophageal cancer	0.00947	0.0129	CcSEcCtD
Nitazoxanide—Acetylsalicylic acid—PTGS2—esophageal cancer	0.00892	0.0338	CrCbGaD
Nitazoxanide—Alanine aminotransferase increased—Capecitabine—esophageal cancer	0.00892	0.0121	CcSEcCtD
Nitazoxanide—Influenza—Capecitabine—esophageal cancer	0.00874	0.0119	CcSEcCtD
Nitazoxanide—Dysuria—Capecitabine—esophageal cancer	0.00817	0.0111	CcSEcCtD
Nitazoxanide—Flatulence—Cisplatin—esophageal cancer	0.00814	0.0111	CcSEcCtD
Nitazoxanide—Muscle spasms—Cisplatin—esophageal cancer	0.00794	0.0108	CcSEcCtD
Nitazoxanide—Tremor—Cisplatin—esophageal cancer	0.00774	0.0105	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Cisplatin—esophageal cancer	0.00766	0.0104	CcSEcCtD
Nitazoxanide—Anaemia—Cisplatin—esophageal cancer	0.00763	0.0104	CcSEcCtD
Nitazoxanide—Acetylsalicylic acid—ABCB1—esophageal cancer	0.00758	0.0287	CrCbGaD
Nitazoxanide—Malaise—Cisplatin—esophageal cancer	0.00745	0.0101	CcSEcCtD
Nitazoxanide—Epistaxis—Capecitabine—esophageal cancer	0.00735	0.00998	CcSEcCtD
Nitazoxanide—Myalgia—Cisplatin—esophageal cancer	0.00703	0.00955	CcSEcCtD
Nitazoxanide—Rhinitis—Capecitabine—esophageal cancer	0.00701	0.00953	CcSEcCtD
Nitazoxanide—Hypoaesthesia—Capecitabine—esophageal cancer	0.00696	0.00945	CcSEcCtD
Nitazoxanide—Discomfort—Cisplatin—esophageal cancer	0.00695	0.00944	CcSEcCtD
Nitazoxanide—Pharyngitis—Capecitabine—esophageal cancer	0.00694	0.00943	CcSEcCtD
Nitazoxanide—Oedema—Cisplatin—esophageal cancer	0.00674	0.00916	CcSEcCtD
Nitazoxanide—Infection—Cisplatin—esophageal cancer	0.0067	0.0091	CcSEcCtD
Nitazoxanide—Tachycardia—Cisplatin—esophageal cancer	0.00658	0.00894	CcSEcCtD
Nitazoxanide—Anorexia—Cisplatin—esophageal cancer	0.00642	0.00873	CcSEcCtD
Nitazoxanide—Chills—Capecitabine—esophageal cancer	0.00627	0.00853	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.00614	0.00834	CcSEcCtD
Nitazoxanide—Dysuria—Methotrexate—esophageal cancer	0.00608	0.00826	CcSEcCtD
Nitazoxanide—Flatulence—Capecitabine—esophageal cancer	0.006	0.00815	CcSEcCtD
Nitazoxanide—Back pain—Capecitabine—esophageal cancer	0.00589	0.008	CcSEcCtD
Nitazoxanide—Decreased appetite—Cisplatin—esophageal cancer	0.00586	0.00796	CcSEcCtD
Nitazoxanide—Muscle spasms—Capecitabine—esophageal cancer	0.00585	0.00795	CcSEcCtD
Nitazoxanide—Pain—Cisplatin—esophageal cancer	0.00576	0.00783	CcSEcCtD
Nitazoxanide—Tremor—Capecitabine—esophageal cancer	0.0057	0.00775	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Capecitabine—esophageal cancer	0.00565	0.00768	CcSEcCtD
Nitazoxanide—Anaemia—Capecitabine—esophageal cancer	0.00563	0.00765	CcSEcCtD
Nitazoxanide—Feeling abnormal—Cisplatin—esophageal cancer	0.00555	0.00755	CcSEcCtD
Nitazoxanide—Malaise—Capecitabine—esophageal cancer	0.00549	0.00746	CcSEcCtD
Nitazoxanide—Epistaxis—Methotrexate—esophageal cancer	0.00547	0.00743	CcSEcCtD
Nitazoxanide—Syncope—Capecitabine—esophageal cancer	0.00546	0.00742	CcSEcCtD
Nitazoxanide—Loss of consciousness—Capecitabine—esophageal cancer	0.00535	0.00727	CcSEcCtD
Nitazoxanide—Body temperature increased—Cisplatin—esophageal cancer	0.00533	0.00724	CcSEcCtD
Nitazoxanide—Hypertension—Capecitabine—esophageal cancer	0.00526	0.00714	CcSEcCtD
Nitazoxanide—Myalgia—Capecitabine—esophageal cancer	0.00518	0.00704	CcSEcCtD
Nitazoxanide—Pharyngitis—Methotrexate—esophageal cancer	0.00517	0.00702	CcSEcCtD
Nitazoxanide—Discomfort—Capecitabine—esophageal cancer	0.00512	0.00696	CcSEcCtD
Nitazoxanide—Dry mouth—Capecitabine—esophageal cancer	0.00507	0.00689	CcSEcCtD
Nitazoxanide—Oedema—Capecitabine—esophageal cancer	0.00497	0.00675	CcSEcCtD
Nitazoxanide—Hypersensitivity—Cisplatin—esophageal cancer	0.00497	0.00675	CcSEcCtD
Nitazoxanide—Infection—Capecitabine—esophageal cancer	0.00494	0.00671	CcSEcCtD
Nitazoxanide—Shock—Capecitabine—esophageal cancer	0.00489	0.00664	CcSEcCtD
Nitazoxanide—Tachycardia—Capecitabine—esophageal cancer	0.00485	0.00659	CcSEcCtD
Nitazoxanide—Asthenia—Cisplatin—esophageal cancer	0.00484	0.00657	CcSEcCtD
Nitazoxanide—Anorexia—Capecitabine—esophageal cancer	0.00474	0.00644	CcSEcCtD
Nitazoxanide—Chills—Methotrexate—esophageal cancer	0.00467	0.00635	CcSEcCtD
Nitazoxanide—Diarrhoea—Cisplatin—esophageal cancer	0.00461	0.00627	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.00453	0.00615	CcSEcCtD
Nitazoxanide—Insomnia—Capecitabine—esophageal cancer	0.00449	0.00611	CcSEcCtD
Nitazoxanide—Back pain—Methotrexate—esophageal cancer	0.00438	0.00596	CcSEcCtD
Nitazoxanide—Dyspepsia—Capecitabine—esophageal cancer	0.00437	0.00594	CcSEcCtD
Nitazoxanide—Decreased appetite—Capecitabine—esophageal cancer	0.00432	0.00587	CcSEcCtD
Nitazoxanide—Vomiting—Cisplatin—esophageal cancer	0.00429	0.00582	CcSEcCtD
Nitazoxanide—Rash—Cisplatin—esophageal cancer	0.00425	0.00577	CcSEcCtD
Nitazoxanide—Constipation—Capecitabine—esophageal cancer	0.00425	0.00577	CcSEcCtD
Nitazoxanide—Pain—Capecitabine—esophageal cancer	0.00425	0.00577	CcSEcCtD
Nitazoxanide—Dermatitis—Cisplatin—esophageal cancer	0.00425	0.00577	CcSEcCtD
Nitazoxanide—Ill-defined disorder—Methotrexate—esophageal cancer	0.0042	0.00571	CcSEcCtD
Nitazoxanide—Anaemia—Methotrexate—esophageal cancer	0.00419	0.00569	CcSEcCtD
Nitazoxanide—Feeling abnormal—Capecitabine—esophageal cancer	0.00409	0.00556	CcSEcCtD
Nitazoxanide—Malaise—Methotrexate—esophageal cancer	0.00409	0.00555	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Capecitabine—esophageal cancer	0.00406	0.00552	CcSEcCtD
Nitazoxanide—Nausea—Cisplatin—esophageal cancer	0.004	0.00544	CcSEcCtD
Nitazoxanide—Abdominal pain—Capecitabine—esophageal cancer	0.00393	0.00534	CcSEcCtD
Nitazoxanide—Body temperature increased—Capecitabine—esophageal cancer	0.00393	0.00534	CcSEcCtD
Nitazoxanide—Myalgia—Methotrexate—esophageal cancer	0.00386	0.00524	CcSEcCtD
Nitazoxanide—Discomfort—Methotrexate—esophageal cancer	0.00381	0.00518	CcSEcCtD
Nitazoxanide—Infection—Methotrexate—esophageal cancer	0.00367	0.00499	CcSEcCtD
Nitazoxanide—Hypersensitivity—Capecitabine—esophageal cancer	0.00366	0.00497	CcSEcCtD
Nitazoxanide—Asthenia—Capecitabine—esophageal cancer	0.00356	0.00484	CcSEcCtD
Nitazoxanide—Anorexia—Methotrexate—esophageal cancer	0.00353	0.00479	CcSEcCtD
Nitazoxanide—Pruritus—Capecitabine—esophageal cancer	0.00352	0.00478	CcSEcCtD
Nitazoxanide—Diarrhoea—Capecitabine—esophageal cancer	0.0034	0.00462	CcSEcCtD
Nitazoxanide—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.00337	0.00458	CcSEcCtD
Nitazoxanide—Insomnia—Methotrexate—esophageal cancer	0.00335	0.00455	CcSEcCtD
Nitazoxanide—Somnolence—Methotrexate—esophageal cancer	0.00329	0.00447	CcSEcCtD
Nitazoxanide—Dizziness—Capecitabine—esophageal cancer	0.00329	0.00446	CcSEcCtD
Nitazoxanide—Dyspepsia—Methotrexate—esophageal cancer	0.00326	0.00442	CcSEcCtD
Nitazoxanide—Decreased appetite—Methotrexate—esophageal cancer	0.00322	0.00437	CcSEcCtD
Nitazoxanide—Pain—Methotrexate—esophageal cancer	0.00316	0.0043	CcSEcCtD
Nitazoxanide—Vomiting—Capecitabine—esophageal cancer	0.00316	0.00429	CcSEcCtD
Nitazoxanide—Rash—Capecitabine—esophageal cancer	0.00313	0.00426	CcSEcCtD
Nitazoxanide—Dermatitis—Capecitabine—esophageal cancer	0.00313	0.00425	CcSEcCtD
Nitazoxanide—Headache—Capecitabine—esophageal cancer	0.00311	0.00423	CcSEcCtD
Nitazoxanide—Feeling abnormal—Methotrexate—esophageal cancer	0.00305	0.00414	CcSEcCtD
Nitazoxanide—Gastrointestinal pain—Methotrexate—esophageal cancer	0.00302	0.00411	CcSEcCtD
Nitazoxanide—Nausea—Capecitabine—esophageal cancer	0.00295	0.00401	CcSEcCtD
Nitazoxanide—Abdominal pain—Methotrexate—esophageal cancer	0.00292	0.00397	CcSEcCtD
Nitazoxanide—Body temperature increased—Methotrexate—esophageal cancer	0.00292	0.00397	CcSEcCtD
Nitazoxanide—Hypersensitivity—Methotrexate—esophageal cancer	0.00273	0.0037	CcSEcCtD
Nitazoxanide—Asthenia—Methotrexate—esophageal cancer	0.00265	0.00361	CcSEcCtD
Nitazoxanide—Pruritus—Methotrexate—esophageal cancer	0.00262	0.00356	CcSEcCtD
Nitazoxanide—Diarrhoea—Methotrexate—esophageal cancer	0.00253	0.00344	CcSEcCtD
Nitazoxanide—Dizziness—Methotrexate—esophageal cancer	0.00245	0.00332	CcSEcCtD
Nitazoxanide—Vomiting—Methotrexate—esophageal cancer	0.00235	0.0032	CcSEcCtD
Nitazoxanide—Rash—Methotrexate—esophageal cancer	0.00233	0.00317	CcSEcCtD
Nitazoxanide—Dermatitis—Methotrexate—esophageal cancer	0.00233	0.00317	CcSEcCtD
Nitazoxanide—Headache—Methotrexate—esophageal cancer	0.00232	0.00315	CcSEcCtD
Nitazoxanide—Nausea—Methotrexate—esophageal cancer	0.0022	0.00299	CcSEcCtD
